Home/Filings/4/0001415889-22-012795
4//SEC Filing

INGRAM ROBERT ALEXANDER 4

Accession 0001415889-22-012795

CIK 0001701541other

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 9:14 PM ET

Size

5.7 KB

Accession

0001415889-22-012795

Insider Transaction Report

Form 4
Period: 2022-12-16
Transactions
  • Award

    Common Stock

    2022-12-16$1.50/sh+9,375$14,06342,854 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 15, 2022.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001219890

Filing Metadata

Form type
4
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 9:14 PM ET
Size
5.7 KB